glp-1 vs zepbound Weight Loss: Is or Wegovy More Effective? What to do if you
Description
Supports modest weight reduction
2021Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
Tirzepatide is a dual GLP-1 and GIP receptor agonist, meaning it activates two separate hormonal pathways simultaneously
Discuss your needs with our analyst Please share your requirements with more details so our analyst can check if they can solve your problem(s)
